
Chemours (CC) Q4 Earnings Beat, Revenue Miss Estimates
Chemours (CC) fourth-quarter earnings beat estimates, while sales miss despite growth across TT and TSS segments.

Why Chemours Stock Is Plunging Today
Chemours beat estimates in the fourth quarter, but the news was overshadowed by an update on an ongoing probe into the company's accounting practices. Chemours is facing a challenging environment e...

Chemours Stock Drops As Accounting Probe, Soft Outlook Overshadow Earnings Beat
Shares in chemicals maker Chemours (CC) were down more than 8% in premarket trading Thursday morning as the disclosure of further details relating to an internal accounting probe and a soft current...

Chemours (CC) Q4 Earnings Top Estimates
Chemours (CC) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to break-even earnings per share a year ago.

Is Chemours (CC) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...

Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call.

Should Value Investors Buy Chemours (CC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...

Why Chemours Stock Soared Today
Chemours concluded an internal review it announced last week. The review found that three executives shifted the timing of payables and receivables to meet free cash flow targets and bolster their ...

Why Chemours Stock Crashed 37% This Morning
Chemours delayed issuance of its financial reports for Q4 and 2023 this morning. Management warned that when it does report, it will report a loss.

Chemours Craters. Accounting Issues Delay Earnings.
The company's board has also placed both its CEO and CFO on administrative leave.

Chemical giant Chemours delays quarterly earnings release, internal review underway
Chemours Co.'s stock dropped more than 4% in the extended session Tuesday after the chemicals company delayed its quarterly financial results, saying it “needs additional time.”

Chemours (CC), DuPont & Corteva Back U.S. Water System Deal
Chemours (CC), DuPont & Corteva do not intend to exercise the opt-out option and extend support to PFAS Deal with the U.S. Water System.

Chemours: Technological Innovation Presents Excellent Opportunities For Growth
Chemours Company has significant potential despite its leveraged debt profile, resulting in a buy rating. The company operates in three main segments: Advanced Performance Materials, Thermal and Sp...

Chemours (CC) Sets Up International F-gas Lifecycle Program
This program by Chemours (CC) will incorporate worldwide monitoring to stimulate further adoption, partnerships and reclamation.

Companies agree to pay $110M settlement for PFAS chemicals in Ohio
The Chemours Co. CC said Wednesday it reached a settlement with the State of Ohio along with DuPont de Nemours Inc. DD and Corteva Inc. CTVA for $110 million to resolve claims related to the manufa...
Related Companies